MDC1 and neoplasm: Although MDC1 expression failed to show significant correlations with clinical stage and menopause, a strong trend was observed between tumor grade (P = 0.09) and chemotherapy treatment status (P = 0.06), warranting further investigations of this protein as a potential SOC prognostic biomarker.